Daelynn R. Buelow

1.1k total citations
33 papers, 688 citations indexed

About

Daelynn R. Buelow is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Daelynn R. Buelow has authored 33 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 17 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Daelynn R. Buelow's work include Acute Myeloid Leukemia Research (19 papers), Protein Degradation and Inhibitors (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Daelynn R. Buelow is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Protein Degradation and Inhibitors (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Daelynn R. Buelow collaborates with scholars based in United States, Canada and Malaysia. Daelynn R. Buelow's co-authors include Tracy Raivio, Michael E. Konkel, Jason M. Neal‐McKinney, Nancy L. Price, Sharyn D. Baker, Randall T. Hayden, Jeffrey E. Christensen, Zhengming Gu, Stanley Pounds and Thomas J. Walsh and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Daelynn R. Buelow

32 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daelynn R. Buelow United States	16	320	168	123	116	103	33	688
Jennifer E. Oyler United States	9	260 0.8×	108 0.6×	58 0.5×	122 1.1×	51 0.5×	10	696
A.B. Schryvers Canada	12	339 1.1×	260 1.5×	104 0.8×	65 0.6×	151 1.5×	13	883
James L. Smith United States	15	256 0.8×	124 0.7×	52 0.4×	57 0.5×	33 0.3×	22	603
Michael D. Lundrigan United States	16	610 1.9×	456 2.7×	102 0.8×	115 1.0×	60 0.6×	22	923
Chi Nam Ignatius Pang Australia	17	654 2.0×	180 1.1×	139 1.1×	22 0.2×	21 0.2×	42	1.0k
Marcella Facchini Italy	11	372 1.2×	107 0.6×	88 0.7×	68 0.6×	31 0.3×	15	639
Charles Calmettes Canada	14	294 0.9×	120 0.7×	63 0.5×	42 0.4×	37 0.4×	24	567
Sreejesh Shanker United States	17	250 0.8×	194 1.2×	429 3.5×	47 0.4×	47 0.5×	26	844
Isabelle Ricard France	15	187 0.6×	120 0.7×	71 0.6×	66 0.6×	19 0.2×	19	515
Nura Schürmann Switzerland	6	500 1.6×	195 1.2×	94 0.8×	182 1.6×	16 0.2×	7	926

Countries citing papers authored by Daelynn R. Buelow

Since Specialization

Citations

This map shows the geographic impact of Daelynn R. Buelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daelynn R. Buelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daelynn R. Buelow more than expected).

Fields of papers citing papers by Daelynn R. Buelow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daelynn R. Buelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daelynn R. Buelow. The network helps show where Daelynn R. Buelow may publish in the future.

Co-authorship network of co-authors of Daelynn R. Buelow

This figure shows the co-authorship network connecting the top 25 collaborators of Daelynn R. Buelow. A scholar is included among the top collaborators of Daelynn R. Buelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daelynn R. Buelow. Daelynn R. Buelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicolet, Deedra, Daelynn R. Buelow, Shelley Orwick, et al.. (2025). Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies. Leukemia. 39(3). 623–631. 1 indexed citations

Mims, Alice S., Lai Wei, Eric McLaughlin, et al.. (2025). Revumenib in combination with intensive induction and consolidation for newly diagnosed patients with NPM1-mutated or KMT2A-rearranged Acute Myeloid Leukemia: Preliminary results from the Phase 1b etctn 10596 study. Blood. 146(Supplement 1). 5206–5206.

Bhatnagar, Bhavana, Jessica Kohlschmidt, Shelley Orwick, et al.. (2023). Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood Advances. 7(16). 4671–4675. 1 indexed citations

Buelow, Daelynn R., Bhavana Bhatnagar, Shelley Orwick, et al.. (2022). BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors. Blood Advances. 6(17). 5049–5060. 7 indexed citations

Eisenmann, Eric D., Kevin M. Huang, Daelynn R. Buelow, et al.. (2022). TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers. 15(1). 29–29. 7 indexed citations

Kohlschmidt, Jessica, Daelynn R. Buelow, Shelley Orwick, et al.. (2022). Molecular and Clinical Features of FLT3 Juxtamembrane Domain Point Mutations (muts) in Acute Myeloid Leukemia (AML). Blood. 140(Supplement 1). 6244–6246. 1 indexed citations

Buelow, Daelynn R., Mingshan Niu, Eric D. Eisenmann, et al.. (2020). TP-0903 is active in models of drug-resistant acute myeloid leukemia. JCI Insight. 5(23). 21 indexed citations

Zhao, Qiuhong, Daelynn R. Buelow, Mitch A. Phelps, et al.. (2019). Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML. Investigational New Drugs. 38(2). 340–349. 32 indexed citations

Buelow, Daelynn R., et al.. (2019). Activity of TP‐0903 in FLT3 inhibitor resistant AML models. The FASEB Journal. 33(S1). 1 indexed citations

10.

Drenberg, Christina D., Anang A. Shelat, Jinjun Dang, et al.. (2019). A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. Nature Communications. 10(1). 2189–2189. 20 indexed citations

11.

Park, Il‐Kyoo, Daelynn R. Buelow, Clifford J. Whatcott, et al.. (2017). TP-0903, a Novel Axl Inhibitor with Activity in Drug Resistant FLT3-ITD+ AML through a Mechanism That Includes FLT3 Inhibition. Blood. 130. 2522–2522. 1 indexed citations

12.

Hu, Shuiying, et al.. (2016). ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression. Clinical and Translational Science. 9(1). 51–59. 27 indexed citations

13.

Buelow, Daelynn R., Yilun Sun, Li Tang, et al.. (2016). Comparative Evaluation of Four Real-Time PCR Methods for the Quantitative Detection of Epstein-Barr Virus from Whole Blood Specimens. Journal of Molecular Diagnostics. 18(4). 527–534. 14 indexed citations

14.

Inaba, Hiroto, John C. Panetta, Daelynn R. Buelow, et al.. (2016). Pilot Study of Combined Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib with Sorafenib in Pediatric Patients with Relapsed/Refractory FLT3+Ve AML. Blood. 128(22). 3937–3937. 2 indexed citations

15.

Tang, Li, Yilun Sun, Daelynn R. Buelow, et al.. (2016). Quantitative Assessment of Commutability for Clinical Viral Load Testing Using a Digital PCR-Based Reference Standard. Journal of Clinical Microbiology. 54(6). 1616–1623. 11 indexed citations

16.

Gu, Zhengming, Daelynn R. Buelow, Rūta Petraitienė, et al.. (2014). Quantitative Multiplexed Detection of Common Pulmonary Fungal Pathogens by Labeled Primer Polymerase Chain Reaction. Archives of Pathology & Laboratory Medicine. 138(11). 1474–1480. 12 indexed citations

17.

Buelow, Daelynn R., et al.. (2013). Comparison of two multiplexed PCR assays for the detection of HSV-1, HSV-2, and VZV with extracted and unextracted cutaneous and mucosal specimens. Journal of Clinical Virology. 58(1). 84–88. 16 indexed citations

18.

Buelow, Daelynn R., Zhengming Gu, Thomas J. Walsh, & Randall T. Hayden. (2012). Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. Medical Mycology. 50(7). 775–780. 18 indexed citations

19.

Buelow, Daelynn R., Jeffrey E. Christensen, Jason M. Neal‐McKinney, & Michael E. Konkel. (2011). Campylobacter jejuni survival within human epithelial cells is enhanced by the secreted protein CiaI. Molecular Microbiology. 80(5). 1296–1312. 60 indexed citations

20.

Buelow, Daelynn R. & Tracy Raivio. (2009). Three (and more) component regulatory systems – auxiliary regulators of bacterial histidine kinases. Molecular Microbiology. 75(3). 547–566. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact